BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9565461)

  • 21. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of ascites in cirrhosis.
    Wong F
    J Gastroenterol Hepatol; 2012 Jan; 27(1):11-20. PubMed ID: 21916992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluid and electrolyte management of ascites in patients with cirrhosis.
    Bass M
    Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of ascites in liver cirrhosis].
    Gramkow M; Christensen E
    Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of peritoneal port-systems in the treatment of diuretic-resistant cirrhotic ascites].
    Abdurakhmanov BA; Gantsev ShKh; Kulakeev OK
    Khirurgiia (Mosk); 2010; (4):30-3. PubMed ID: 20517235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
    Borie DC; Vaillant JC; Breton S; Hannoun L
    Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic program for ascites. Recommendations from the Swedish Society of Gastroenterology and Gastrointestinal Endoscopy].
    Lööf L; Prytz H; Söderlund C; Wallerstedt S
    Lakartidningen; 2001 Dec; 98(49):5649-52, 5655. PubMed ID: 11783052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
    Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou JP; Erlinger S
    J Hepatol; 1996 Aug; 25(2):135-44. PubMed ID: 8878773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.
    Arroyo V
    Acta Gastroenterol Belg; 1990; 53(2):249-55. PubMed ID: 2267904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complications and reoperations after peritoneo-atrial shunting in patients with liver cirrhosis and diuretic-resistant ascites].
    Vakhidov AV; Nazyrov FG; Akilov KhA; Deviatov AV; Mansurov AA
    Klin Khir (1962); 1991; (9):10-2. PubMed ID: 1766164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory ascites.
    Runyon BA
    Semin Liver Dis; 1993 Nov; 13(4):343-51. PubMed ID: 8303315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.